Page 194 - PRECONGRESS COURSE 06

D
D
u
ua
a
l
l
t
t
r
r
i
i
g
g
g
g
e
er
ri
i
n
n
g
go
of
ff
f
i
in
n
a
al
l
o
oo
oc
cy
y
t
t
e
e
m
m
a
at
t
u
u
r
r
a
at
ti
io
on
n
w
wi
it
t
h
ht
th
he
ec
co
o
m
mb
b
i
in
n
a
at
ti
i
o
o
n
no
o
f
f
G
Gn
n
R
R
H
Ha
ag
g
o
o
n
n
i
is
st
ta
an
n
d
d
h
hC
CG
G
12
10
8
6
4
2
0
0.0
normal hCG dose ‐ low risk pa ents Lin et al 2013
0.0
low hCG dose ‐ high risk pa ents Griffin et al 2012
0.0
low hCG dose ‐ high risk pa ents Shapiro et al 2008
D
D
u
ua
a
l
l
t
t
r
r
i
i
g
g
g
g
e
er
ri
i
n
n
g
go
of
ff
f
i
in
n
a
al
l
o
oo
oc
cy
y
t
t
e
e
m
m
a
at
t
u
u
r
r
a
at
ti
io
on
n
w
wi
it
t
h
ht
th
he
ec
co
o
m
mb
b
i
in
n
a
at
ti
i
o
o
n
no
o
f
f
G
Gn
n
R
R
H
Ha
ag
g
o
o
n
n
i
is
st
ta
an
n
d
d
h
hC
CG
G
Conclusions
No severe OHSS cases were observed
when a high dose of hCG is given concomitantly with GnRH agonist triggering in low risk for OHSS patients
No severe OHSS cases were observed
when a small dose of hCG is given concomitantly with GnRH agonist triggering in high risk patients
194
Page 190 of 258
Severe OHSS incidence % 95% CI